These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 19399946)

  • 21. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL; Camargo CA; Anwaruddin S; Baggish AL; Chen AA; Krauser DG; Tung R; Cameron R; Nagurney JT; Chae CU; Lloyd-Jones DM; Brown DF; Foran-Melanson S; Sluss PM; Lee-Lewandrowski E; Lewandrowski KB
    Am J Cardiol; 2005 Apr; 95(8):948-54. PubMed ID: 15820160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
    Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic values of NT-proBNP in acute dyspnea among elderly patients.
    Su Q; Liu H; Zhang X; Dang W; Liu R; Zhao X; Yuan X; Qin Y; Zhang J; Chen C; Xia Y
    Int J Clin Exp Pathol; 2015; 8(10):13471-6. PubMed ID: 26722559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic significance of NT-proBNP estimation in patients with acute dyspnea.
    Shaikh K; Ahmad M
    J Coll Physicians Surg Pak; 2011 Oct; 21(10):584-8. PubMed ID: 22015116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
    Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
    Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
    Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
    J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung ultrasound integrated with clinical assessment for the diagnosis of acute decompensated heart failure in the emergency department: a randomized controlled trial.
    Pivetta E; Goffi A; Nazerian P; Castagno D; Tozzetti C; Tizzani P; Tizzani M; Porrino G; Ferreri E; Busso V; Morello F; Paglieri C; Masoero M; Cassine E; Bovaro F; Grifoni S; Maule MM; Lupia E;
    Eur J Heart Fail; 2019 Jun; 21(6):754-766. PubMed ID: 30690825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure.
    Robaei D; Koe L; Bais R; Gould I; Stewart T; Tofler GH
    Ann Clin Biochem; 2011 May; 48(Pt 3):212-7. PubMed ID: 21398433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Importance of surfactant proteins B and D for the differential diagnosis of acute dyspnea].
    Lüers C; Hagenah G; Wachter R; Kleta S; Schaumberg J; Riedel S; Binder L; Jung K; Schmidt A; Pieske B
    Med Klin (Munich); 2010 Sep; 105(9):611-8. PubMed ID: 20878298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Lyngbakken MN; Pervez MO; Brynildsen J; Pedersen MH; Sølvernes J; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2018 Feb; 52():41-47. PubMed ID: 29074091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
    Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
    Baggish AL; van Kimmenade RR; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the Role of Plasma NT-proBNP in the Diagnosis of Heart Failure.
    Athavale B; Pathak J
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.